Microglia in the brain express TREM2 and mutations of TREM2 impact its ability to bind ligands, diminish microglial activation, and accelerate progression of Alzheimer’s Disease (21). This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.